I. Sandri

DPYD Genotyping as a Potential Cost-effective Predictive Biomarker of Capecitabine Toxicity in Breast Cancer

L. Karapanagiotou, J. Mansi, D. Papadatos-Pastos, 2015 .

Prediction of therapy response in bone-predominant metastatic breast cancer: comparison of [18F] fluorodeoxyglucose and [18F]-fluoride PET/CT with whole-body MRI with diffusion-weighted imaging

V. Goh, G. Cook, J. Mansi, 2018, European Journal of Nuclear Medicine and Molecular Imaging.

Planned and unplanned pregnancies in breast cancer survivors.

J. Mansi, A. Shewbridge, J. Kopeika, 2019, Breast.